Sign in
4

Changes in Ownership

Aldeyra Therapeutics, Inc. Filed Acc 0000904454-17-000440

Options or other derivatives

  • Director acquired 22,368 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

TREU JESSE I · Director

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2017-06-08 Grant or award : show line 1 in the form Stock Option (right to buy) +17,776 17,776 D
2017-06-08 Grant or award : show line 2 in the form Stock Option (right to buy) +2,222 2,222 D
2017-06-08 Grant or award : show line 3 in the form Stock Option (right to buy) +2,370 2,370 D
Loading xslF345X03/edgar.xml…